Oncopeptides’ 25 largest shareholders
Information provided by MFN. Updated quarterly.
| Name | ONCO | ONCO C | Capital | Votes | Verified |
|---|---|---|---|---|---|
| HealthCap VIII L.P. | 45,616,834 | 11.54% | 11.92% | 2026-09-28 | |
| HealthCap VI L.P. | 15,562,345 | 3.94% | 4.07% | 2026-09-28 | |
| Avanza Pension | 20,200,927 | 5.11% | 5.28% | 2026-09-28 | |
| Oncopeptides AB | 13,929,245 | 3.52% | 0.36% | 2026-09-28 | |
| Nordnet Pensionsförsäkring | 10,522,261 | 2.66% | 2.75% | 2026-09-28 | |
| Handelsbanken Funds | 8,266,617 | 2.09% | 2.16% | 2026-09-30 | |
| SEB Funds | 2,834,700 | 0.72% | 0.74% | 2026-08-31 | |
| Magnus Karlsson | 2,700,000 | 0.68% | 0.71% | 2026-08-27 | |
| Swedbank Försäkring | 2,515,504 | 0.64% | 0.66% | 2026-09-28 | |
| Jakob Lindberg | 2,348,201 | 0.59% | 0.61% | 2026-09-28 | |
| Per Wold-Olsen | 2,065,678 | 0.52% | 0.54% | 2026-06-09 | |
| Storebrand Asset Management | 2,041,343 | 0.52% | 0.53% | 2026-09-30 | |
| Ulf Nolén | 1,950,000 | 0.49% | 0.51% | 2026-09-28 | |
| Försäkringsaktiebolaget Skandia | 1,871,276 | 0.47% | 0.49% | 2026-09-28 | |
| Ingrid Hedbom | 1,850,000 | 0.47% | 0.48% | 2026-09-28 | |
| Handelsbanken Liv Försäkring AB | 1,802,344 | 0.46% | 0.47% | 2026-09-28 | |
| Zetterstedt Holding AB | 1,800,000 | 0.46% | 0.47% | 2026-09-28 | |
| Lennart Stenberg | 1,664,504 | 0.42% | 0.43% | 2026-09-28 | |
| Nordea Liv & Pension | 1,439,891 | 0.36% | 0.38% | 2026-09-28 | |
| Axel Härstedt | 1,243,161 | 0.31% | 0.32% | 2026-09-28 | |
| Timmy Jansson | 1,232,849 | 0.31% | 0.32% | 2026-09-28 | |
| Hasan Taspinar | 1,200,080 | 0.30% | 0.31% | 2026-09-28 | |
| Kjell Hasslert | 1,187,554 | 0.30% | 0.31% | 2026-09-28 | |
| Johan Zetterstedt | 1,105,527 | 0.28% | 0.29% | 2026-09-28 | |
| Skandia Fonder | 1,104,923 | 0.28% | 0.29% | 2026-09-30 | |
| Douglas Storckenfeldt | 1,100,000 | 0.28% | 0.29% | 2026-09-28 | |
| Total 25 | 135,226,519 | 13,929,245 | 37.72% | 35.69% | |
| Others | 246,131,239 | 0 | 62.28% | 64.31% | |
| Total | 381,357,758 | 13,929,245 | 100.00% | 100.00% |